Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Healthy Han Chinese, Korean, Japanese, and Caucasian Participants and the Effects of Rifampin on the Pharmacokinetics of Intranasally Administered Esketamine
Clinical trial NCT02846519 · COMPLETED
Trial details
- NCT number
- NCT02846519
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-26
- Primary completion
- 2016-05-28
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.